SystimaNX
Back to case studies
Healthcare & Life SciencesAI Strategy & MLOpsCloud Infrastructure

Regulated Data Platform & ML Pipeline

HIPAA-aligned analytics and model delivery for a national care network, built to give clinical and data science teams governed self-service access without opening new privacy risk.

Faster insights without trading off privacy controls
Client
Confidential — healthcare
Industry
Healthcare & Life Sciences
Timeline
7 months
Technologies
6+ tools

The Challenge

!Patient, claims, and operational data lived in more than a dozen siloed systems across regional care sites, so building a single cohort for clinical research meant weeks of manual reconciliation before a single query could run. Analysts routinely discovered mismatched patient identifiers and inconsistent coding across facilities, which forced repeated rework and delayed time-sensitive studies.
!Business Associate Agreements with partner health systems and state-level residency rules constrained where protected health information could be stored, processed, and used for model training. Any new data source required a fresh legal review, and the platform had no automated way to enforce those boundaries at the infrastructure level.
!Data scientists depended on platform engineers to manually provision compute, mount storage, and configure access for every new project, creating a queue that stretched onboarding for a new model from days into multiple weeks. These handoffs also introduced inconsistent environments, so results were hard to reproduce across teams.
!There was no consistent way to trace which dataset version, feature set, or code commit produced a given model, making it difficult to satisfy internal model risk reviews. When an auditor or compliance officer asked how a prediction was generated, the answer often required reconstructing history from emails and shared drives.
!Access reviews for sensitive clinical tables were performed via spreadsheet on a quarterly cadence, well behind the pace of staff turnover and project changes. Former contractors and rotated staff sometimes retained access to de-identified extracts long after their engagement ended.
!De-identification of patient records before analytics use was a manual, script-based process with no standard validation step, so the risk of residual identifiers slipping into a research extract was a recurring concern for the privacy office. Each new data domain needed its own bespoke masking logic.
!Security, clinical informatics, and data engineering teams operated from separate roadmaps and tooling, which meant that compliance requirements were often discovered after a pipeline was already built rather than designed in from the start. This caused late-stage rework on projects that were otherwise ready to ship.
!Existing infrastructure lacked network-level isolation between research, staging, and production tiers, so a misconfigured job in one environment could theoretically reach data it had no business touching, a gap flagged in the network's most recent third-party risk assessment.

Our Solution

Designed and deployed a lakehouse-style data platform on Databricks with tiered network isolation, customer-managed KMS encryption keys, and segmented storage so that raw PHI, de-identified research data, and model artifacts each sat behind distinct access boundaries. This gave the security team a clear perimeter to audit instead of a flat, shared environment.
Stood up a full MLOps stack using MLflow for experiment tracking and a model registry with staged promotion gates, so every model version carried its lineage back to the exact data snapshot, feature set, and training code that produced it. Promotion from staging to production now requires passing automated validation checks rather than a manual sign-off email.
Built automated de-identification pipelines in Apache Airflow with built-in validation and statistical sampling checks that flag any residual identifiers before data reaches the research zone, replacing the prior ad-hoc scripts with a repeatable, auditable process. Each pipeline run produces a validation report the privacy office can review directly.
Integrated role-based access control with the network's existing identity provider, adding time-boxed break-glass procedures for analysts who need temporary elevated access during active incidents or urgent studies. Access grants now expire automatically instead of persisting indefinitely.
Automated quarterly access reviews by generating system-of-record reports directly from the IdP and data platform, cutting the manual spreadsheet exercise down to a verification step rather than a full audit from scratch. Reviewers now approve or revoke access in a single workflow instead of chasing down owners by email.
Provisioned infrastructure as code with Terraform and orchestrated workloads on Kubernetes, giving data science teams self-service environments that come pre-configured with the correct network policies and access scopes for their project tier. New project onboarding dropped from a multi-week ticket queue to a same-day request.
Documented a full control matrix mapping each technical safeguard to its corresponding HIPAA and BAA obligation, giving compliance officers a single reference for internal audits and external partner reviews. This matrix is now maintained as a living document alongside the infrastructure code.
Brought security, clinical informatics, and platform engineering onto a shared roadmap with joint design reviews before any new pipeline was built, so compliance requirements were addressed at design time instead of being retrofitted after the fact.

Measurable Impact

Time to insight
3-5x faster

Approved analysts run governed queries against curated datasets in hours instead of the 1-2 weeks previously needed for bespoke data extracts.

Model delivery
100% of promotions pass automated lineage checks

Promotions from staging to production follow an automated checklist with a full audit trail from data to deployment, replacing manual sign-off emails.

Risk posture
Zero unmonitored PHI copies found post-launch

Sensitive data no longer accumulates in ad-hoc copies outside approved, monitored stores, closing the gap flagged in the prior risk assessment.

Access review cycle
Reduced from ~3 weeks to under a day

Quarterly access recertification is now a verification pass over system-generated reports rather than a manual spreadsheet audit.

Onboarding time
From 2-3 weeks to same-day

New data science projects get self-service, pre-configured environments instead of waiting in a manual provisioning queue.

Collaboration
Joint design reviews on 100% of new pipelines

Clinical, data, and security stakeholders now share a single roadmap and design review process before any pipeline is built.

Audit readiness
Single control matrix covering all safeguards

A documented control matrix ties every safeguard to a specific compliance obligation, ready for internal and partner review, down from history reconstructed ad hoc.

We needed science velocity inside a regulated box. The platform team delivered both, without cutting corners on patient privacy. What used to take our analysts weeks of manual extract requests now happens through governed self-service, and our auditors finally have a single control matrix instead of a scavenger hunt.

C
Chief data officer
CDO, healthcare network (NDA)

Technology stack

DatabricksAzure Health Data ServicesMLflowKubernetesTerraformApache Airflow
Book a consultation
Regulated Data Platform & ML Pipeline | Case Study | SystimaNX